Skip to main content
Caplight Logo









Journey Clinical

Journey Clinical

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.journeyclinical.com/

Last Round

Series A

Jan 24, 2023

Total Funding Raised

$11.5M

Company Overview

Journey Clinical is a healthtech company that provides a platform for licensed mental health professionals to deliver Psychedelic-Assisted Psychotherapy (PAP), starting with Ketamine-Assisted Psychotherapy (KAP).

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Vertical SaaS, Telemedicine

Business Model

B2B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

ketamine-assisted psychotherapyKAPpsychedelic-assisted therapymental health platformvertical SaaStelemedicineclinical infrastructureHIPAA-compliant platformbehavioral healththerapist trainingpractice managementpsychedelic medicinemedical oversightB2B2CAI clinical scribe

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Journey Clinical Comparables

Compare Journey Clinical with similar companies based on industry and business-model similarity.

Journey Clinical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Osmind
72%
Fluence
69%
Alma
67%

Journey Clinical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 24, 2023
SeedSep 30, 2021

Key People

Founding team and executive leadership

Myriam Barthes

Co-Founder & CEO

Founding Team

Journey Clinical Investors

Notable investors and investment history

Journey Clinical investors
InvestorRounds
AlleyCorpSeries A
Able PartnersSeries A
Union Square VenturesSeries A
GaingelsSeries A
Lionheart VenturesSeed
Mystic VenturesSeries A
Palo SantoSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 15, 2025

    Offering in-person monitoring for Spravato® treatments.

  • Oct 15, 2025

    Will provide Ketamine-Assisted Psychotherapy (KAP) education for group members.

Journey Clinical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Journey Clinical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Journey Clinical's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range102
Year Founded2020
Last FundingJan 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?